Ergocalciferol Capsule, Liquid Filled
NDC Package 69452-151-20
Package Information
Ergocalciferol capsules is vitamin D (ergocalciferol-D2, cholecalciferol-D3, alfacalcidol) is a fat-soluble vitamin that helps your body absorb calcium and phosphorus. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Bionpharma Inc., this product is identified by NDC 69452-151 and is authorized under FDA application ANDA080704.
Identification & Billing
- RxCUI: 1367410 - ergocalciferol 1.25 MG (50,000 UNT) Oral Capsule
- RxCUI: 1367410 - ergocalciferol 1.25 MG Oral Capsule
- RxCUI: 1367410 - vitamin D 1.25 MG Oral Capsule
- RxCUI: 1367410 - vitamin D2 1250 MCG Oral Capsule
- RxCUI: 1367410 - vitamin D2 50,000 UNT Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69452 - Bionpharma Inc.
- 69452-151 - Ergocalciferol
- 69452-151-20 - 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
- 69452-151 - Ergocalciferol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69452-151-20 identifies a specific commercial package of 100 capsule, liquid filled in 1 bottle, plastic of Ergocalciferol, a human prescription drug labeled by Bionpharma Inc.. This capsule, liquid filled is formulated for oral use and contains ergocalciferol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bionpharma Inc. on June 15, 2016. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Vitamin D (ergocalciferol-D2, cholecalciferol-D3, alfacalcidol) is a fat-soluble vitamin that helps your body absorb calcium and phosphorus. Having the right amount of vitamin D, calcium, and phosphorus is important for building and keeping strong bones. Vitamin D is used to treat and prevent bone disorders (such as rickets, osteomalacia). Vitamin D is made by the body when skin is exposed to sunlight. Sunscreen, protective clothing, limited exposure to sunlight, dark skin, and age may prevent getting enough vitamin D from the sun. Vitamin D with calcium is used to treat or prevent bone loss (osteoporosis). Vitamin D is also used with other medications to treat low levels of calcium or phosphate caused by certain disorders (such as hypoparathyroidism, pseudohypoparathyroidism, familial hypophosphatemia). It may be used in kidney disease to keep calcium levels normal and allow normal bone growth. Vitamin D drops (or other supplements) are given to breast-fed infants because breast milk usually has low levels of vitamin D.
How is this Bionpharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69452015120. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.